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Background and purpose: Renal dysfunction (i.e. a reduced estimated glomerular filtration rate, eGFR) is commonly found in hospitalised stroke patients but its associations with patients’ characteristics and outcome require further investigation. 
Methods: We linked clinical data from stroke patients enrolled between 2005 and 2008 into two prospective hospital registers with routine laboratory eGFR data. The eGFR was calculated using the Modification of Diet in Renal Disease (MDRD) method and renal dysfunction was defined as <60 ml/Min/1.73 m2. In addition we systematically reviewed studies investigating the association between eGFR and outcome after stroke.
Results: Of 2520 patients who had an eGFR measured on admission hospital, 805 (32%) had renal dysfunction. On multivariate analysis, renal dysfunction was significantly less likely in those with a predicted good outcome (OR 0.27, 95% CI 0.21, 0.36) based on the well validated Six Simple Variable (SSV) model. After adjustment for other predictive factors, stroke patients with renal dysfunction were more likely to die in hospital compared with those without (OR 1.59, 95% CI 1.26, 2.00). Of the 31 studies involving 41896 participants included in the systematic review, 18 studies found that low eGFR was an independent predictor of death and 6 reported a significant association with death and disability.




Renal dysfunction, defined as a low estimated Glomerular Filtration Rate (eGFR) (<60ml/min/1.73m2), is independently associated with the risk of first-ever stroke in the general population (1). Clinical guidelines therefore recommend screening patients at risk of cardiovascular disease for renal dysfunction with eGFR (2).   There are also concerns that renal dysfunction in the acute phase of stroke is associated with: increased bleeding risk after an ischaemic stroke (IS) (3), reduced efficacy of thrombolysis  (4), adverse effects of contrast agents used for multimodel tomography (CT) imaging (5), the high frequency of dehydration (6), and the safety of renally excreted medications, including the new anticoagulants (7).





We included all consecutive stroke admissions prospectively registered in the Scottish Stroke Care Audit  (SSCA) from two teaching hospitals within 14 days of stroke onset between 1st of January 2005 and 30th of December 2008 (9). We included patients with first ever recorded IS and intracerebral haemorrhage (ICH) stroke, but excluded those with subarachnoid haemorrhage using brain imaging. We also excluded patients who had a stroke while in-hospital or who had transient ischaemic attack (TIA, symptoms <24 hours duration).  The SSCA did not record if patients had chronic renal dysfunction prior to admission, therefore these patients are included in the analyses.  To adjust for stroke severity we used the SSV model (age, living alone, independence in activities of daily living before the stroke, the verbal component of the Glasgow Coma Scale, arm power, and the ability to walk) to predict outcomes after stroke (8).

Ethics 
Full ethical approval was not required as it aimed to inform local practice, involved linking routinely available datasets and did not involve any patient identifiable data. The study was approved by the Caldicott Guardian.

Measurements and outcomes
Estimated GFR was calculated using the MDRD equation with the formula for Isotope Dilution Mass Spectrometry (IDMS) = 175 x [serum creatinine, SCr]-1.154 x [age]-0.203 x 0.742 (if female) (2). However, between 2005-2007 the SCr was not standardised to IDMS, so a factor of 186 (rather than 175) was used when using non-IDMS spectrometry (10). Ethnicity was not included in the equation as almost all the population admitted to the hospitals during this period were white. As recommended by the National Kidney Foundation our laboratory reported normal renal function over 60 as >60 due to the tendency for MDRD equation to underestimate normal function (2). Renal dysfunction was therefore defined as <60ml/min/1.73 m2 (2). We further categorised renal dysfunction into moderate (eGFR = 30-59 ml/min/1.73 m2) and severe (<30 ml/min/1.73 m2). 

Analyses
Univariate associations between renal dysfunction, the SSV model and other available clinical factors were investigated with Chi-square tests. Logistic regression models were used to identify independent associations between the significant explanatory factors in the univariate analysis and renal dysfunction and then to determine the association with renal dysfunction and patient outcomes at hospital discharge. Data analyses were performed using IBM SPSS statistics for windows, Version 20.0, 2011 (Armonk, NY: IBM Corp) and SAS Institute Inc, SAS® 9.2 Enhanced Logging Facilities, Cary, NC: SAS Institute Inc., 2008.

Systematic review




A total of 2591 patients were identified in our local cohorts. We excluded 71 (2.7%) patients in whom eGFR could not be calculated.  Of the 2520 remaining patients, 805 (32%) had renal dysfunction.  

Univariate comparisons of clinical characteristics
Table 1 shows stroke patients with renal dysfunction were significantly more likely to be: older; female; prescribed antihypertensive medication, angiotensin converting enzyme (ACE) inhibitors or diuretics; dependent in activities of daily living prior to the stroke; living alone; and unable to talk, not orientated or  unable to walk after the stroke (p<0.05). Neither stroke pathology or clinical classification differed significantly between those with and without renal dysfunction. 

Factors associated with renal dysfunction on admission





Discharge destination was known for 2481 patients (n=39 missing). Stroke patients with moderate (185/690, 27%) and severe (25/102, 25%) renal dysfunction were significantly more likely to die in hospital compared with those without (255/1689, 15%) (Chi-square=52.04, df=4, P<0.0001). After adjustment for other predictive variables, eGFR <60 ml/min/1.73 m2 was found to be an independent predicator of death in-hospital (OR 1.59, 95% CI 1.26, 2.00).  Further analyses of the subcategories of renal dysfunction confirmed that moderate renal dysfunction (eGFR <60 , ≥30 ml/min/1.73 m2) was independently associated with death in hospital (OR 1.67, 95% CI 1.31, 2.13), but severe renal dysfunction (eGFR <30 ml/min/1.73 m2)  was not (OR 1.30, 95% CI 0.78, 2.18).  

Systematic review






This study found that a third of stroke patients had a low eGFR (≤60mL/min/1.73 m2) on the day of admission, which is similar to other studies that used the MDRD equation to estimate GFR (13,22,31,32,37,39,40,42). However, the systematic reviewed found that the prevalence of renal dysfunction in patients with acute stroke varies between 5% to 61% in different populations, depending on the definitions of renal dysfunction used and methods used to calculate eGFR (table 4) (12-42).  We found that low eGFR remained significantly more common in female stroke patients, which may be as a result of differences in the effects of sex hormones on renal physiology as well as responses to ischaemia and reperfusion (43). Patients prescribed diuretics were also more likely to have renal dysfunction and poorer outcomes. However, it remains controversial whether diuretics worsen renal function, perhaps as a result neurohumoral mechanisms, but this requires further investigation in larger prospective studies (44).

This is the first study to use the externally validated SSV model to adjust for prognostic factors (8). Our results support the results of 4 studies included in our systematic review, confirming that low eGFR was an independent predictor of death in-hospital (17,20,25,38). The review also highlights that low eGFR is an independent predictor of poor long-term survival (24,26,29-31,33,35,39,40,41).  However, 12 studies found no significant association between low eGFR and death (12,16,19,21,23,27,36,37,42) and/or combined outcomes of death and disability (12,14,22,34,37,42).  The statistical heterogeneity across studies is probably as a result of the differences in study methodology.  However, our findings and the majority of studies in the review do provide further support to the importance of measuring eGFR on admission to hospital to potentially reduce deleterious effects of renal dysfunction after stroke.  

A major limitation of this study is that renal function was estimated, although direct measurement is expensive and not used in everyday clinical practice.  Our laboratory used the MDRD to calculate eGFR, which has mainly been validated in patients with impaired renal function. However, there is growing support that future studies use the CKD-EPI to calculate eGFR, which may be more accurate in older patients with chronic disease such as stroke (45). Second, eGFR was categorised, rather than used as a continuous measure, and was measured on admission, whereas it would be ideal to verify renal function on several measurements. Third, we did not record previous renal dysfunction or other indicators of renal function, such as proteinuria and microalbuminuria, which others have suggested may more accurately predict stroke outcomes than eGFR (34). The retrospective nature of the analysis, means that we could not study unmeasured confounding such as risk factors, other medications, clinical indices and co-morbidities that might be associated with renal dysfunction. We did try and avoid possible selection bias by retrieving data for all patients in our database during the study period. Fourth, we determined outcomes at hospital discharge, rather than at a fixed time after stroke admission or onset so that our results may be confounded by length of hospital stay. Lastly, meta-analysis would not have been appropriate due to significant methodological heterogeneity across the observational studies included in the systematic review.

Conclusions
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Table 1:  Univariate comparisons of clinical characteristics by eGFR
Characteristic 	 eGFR (mL/min/1.73 m2)	P value
	≥60(n=1715)	<60 (n=805)	
Age (years)	75 (64, 82)	80 (76, 87)	<0.001
Men (n)Length of stay in acute and/or rehabilitation hospital (days)	861 (50%)14 (4,52)	301 (37%)21 (7, 56)	<0.001<0.001
Stroke pathology and subtypeIschaemic stroke Haemorrhagic strokeUncertain Total Anterior Circulation Stroke	1416 (83%)214 (12%)85 (5%)256 (15%)	684 (85%)76 (9%)43 (5%)136 (17%)	      0.074*  0.204
MedicationsAnti-hypertensivesACE inhibitors Diuretics	226 (13%)155 (9%)182 (11%)	138 (17%)101 (13%)144 (18%)	    0.008  0.007<0.001
Predictors of outcome†Independent Lives alone Able to talk Oriented Able to lift both arms Able to walk 	1396 (81%)660 (38%)1359 (79%)1041 (61%)1134 (66%)599 (35%)	551 (68%)344 (43%)596 (74%)394 (49%)505 (63%)200 (25%)	<0.001  0.042  0.003<0.001  0.096<0.001
Outcomes at discharge (missing=39)Discharged homeInstitutional careDead	1192 (71%)  242 (14%)  255 (15%)	457 (58%)125 (16%)210 (27%)	<0.001*
Data are median (IQR) or number (%). *Chi-square (df = 2).   Non-parametric Mann-Whitney tests were used to compare the differences between medians and Chi-square tests for nominal data.  ACE, angiotensin converting enzyme. TACS, total anterior circulation stroke. †Factors included in the SSV model to predict probability of stroke severity (8).


Table 2: Multiple logistic regression analysis showing associations between renal dysfunction and clinical factors on admission.
Variable	Renal dysfunctionOR       (95% CI)       p value
Sex (male v female)Stroke pathology (ICH v IS)Prescribed diuretics Prescribed anti-hypertensive medicationsPrescribed ACE inhibitors Predicted probability of being alive and independent in daily activities at 6 months (SSV model)	      0.68    (0.57, 0.81)     <0.001      0.62    (0.47, 0.83)     <0.001      1.88    (1.47, 2.40)      <0.001      1.13    (0.86, 1.47)        0.383      1.17    (0.85, 1.59)        0.340      0.27    (0.21, 0.36)       <0.001



















Figure 2:  Forest plot of OR (95% confidence intervals) of the effect of eGFR on combined outcomes of death and/or disability at the end of follow-up.
  

Figure 3:  Forest plot of OR (95% confidence intervals) of the effect of eGFR on death at the end of follow-up.






Forest Plot Figures (2, 3, 4) Legend: 
Other definitions of eGFR: *<90*; **≤60 Abbreviations: IS, Ischaemic Stroke; ICH, Intra-Cerebral Haemorrhage; MDRD, Modification of Diet in Renal Disease; JSN CKDI, Japanese Society of Nephrology-Chronic Kidney Disease Initiatives; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; MCQE, Mayo Clinical Quadratic Equation; HD, Hospital Discharge; CI, Confidence Interval; OR, Odds Ratio; HR, Hazards Ratio.
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